# Utilization of MAsS in Patients Undergoing LT for HCC

> **NCT05184283** · — · TERMINATED · sponsor: **Columbia University** · enrollment: 11 (actual)

## Conditions studied

- NAFLD
- Hepatocellular Carcinoma
- Liver Diseases
- Liver Cancer
- Cirrhosis, Liver
- Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05184283
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-16
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Discontinued by Amra Medical due to funding.
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184283, "Utilization of MAsS in Patients Undergoing LT for HCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05184283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*